prof. dr. Tim Lammens
- Work address
-
C. Heymanslaan 10, ingang 10 - verdieping 3
9000 Gent - Tim.Lammens@UGent.be
- ORCID iD
-
0000-0001-8733-4027
Show
Sort by
-
Practice guidelines for the therapeutic drug monitoring of asparaginase in acute lymphoblastic leukemia
-
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer
-
Targeted therapy in juvenile myelomonocytic leukemia : where are we now?
-
In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute leukemia
-
- Journal Article
- A1
- open access
Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs : a multi-phase preclinical study
-
- Journal Article
- A1
- open access
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues
-
- Conference Paper
- C3
- open access
Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma : a BEACON-Neuroblastoma biomarker study
-
- Conference Paper
- C3
- open access
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia